Global Hunter Securities Starts ArQule (ARQL) at Accumulate; Tivantinib NSCLC Success is Key
Tweet Send to a Friend
Global Hunter Securities initiates coverage on ArQule (NASDAQ: ARQL) with an Accumulate. PT $11.
Global analyst says, "ARQL is focused ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Global analyst says, "ARQL is focused ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
